Could a classroom program curb a leading cause of hormonal disorders in teens?
NCT ID NCT07780214
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This trial tests whether a structured educational program, based on the Expanded Health Belief Model, can encourage female high school students to adopt behaviors that protect against polycystic ovary syndrome (PCOS). The program includes sessions on PCOS awareness, perceived risks, and the benefits of healthy habits. Researchers will compare students who receive the program with those who do not, measuring their intention to follow PCOS-protective behaviors. If successful, this approach could offer a simple, school-based way to help young women reduce their risk of a common hormonal condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A structured educational and behavioral program based on the Expanded Health Belief Model, delivered through school sessions to promote PCOS health-protective behaviors.
- What this could lead to
- If effective, this program could become a low-cost, school-based strategy to help young women adopt habits that may lower their risk of developing polycystic ovary syndrome.
- What could go wrong
- This is a small, early-stage trial in a specific group of students, so results may not apply broadly. The program's success depends on whether education alone can change long-term behavior.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 144 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 to 18 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Be female high school students enrolled in the selected schools during the study period. Be within the predefined age range specified in the research protocol (for example, 15-18 years). Be able to read and understand the language used in the intervention and questionnaires. Be willing to participate in the study. Provide informed consent/assent, with parental or guardian consent when required. Be available to participate in all intervention sessions and follow-up assessments. Have no previously diagnosed PCOS, if the purpose is to evaluate preventive health-protective behaviors among students without an existing diagnosis. Not be currently participating in another structured lifestyle or PCOS educational intervention. Exclusion Criteria: Participants may be excluded if they: 1. Have a previously diagnosed PCOS, if the study is designed to focus on prevention among students without PCOS. 2. Have a medical condition that prevents or significantly limits physical activity recommended in the intervention. 3. Have a cognitive, learning, or communication difficulty that prevents them from understanding the intervention or completing the questionnaire. 4. Are currently participating in another structured lifestyle, weight-management, or PCOS educational program. 5. Are receiving a treatment or intervention that could substantially influence the study outcomes. 6. Are absent from a predetermined proportion of intervention sessions (for example, more than 20%-25%). 7. Fail to complete the baseline assessment or required post-intervention assessment. 8. Withdraw their consent/assent at any stage of the study. 9. Become unavailable because of transfer to another school, prolonged absence, or other circumstances that prevent completion of the
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Polycystic ovarain syndrome are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Baghdad
Baghdad, Baghdad Governorate, Iraq